ESR1 and carcinoma: Aim of this study is to identify miRNAs that are differentially expressed in estrogen receptor positive (ER+) and negative (ER−) breast primary tumors to better understand the molecular basis for the phenotypic differences between these two sub-types of carcinomas and to find potential clinically relevant miRNAs.